首页|二仙汤辅治骨质疏松临床研究

二仙汤辅治骨质疏松临床研究

扫码查看
目的:观察二仙汤辅治骨质疏松的效果。方法:88例随机分为对照组和观察组各44例。两组均以常规西药治疗,观察组加用二仙汤治疗。结果:总有效率观察组高于对照组(P<0。05)。观察组中医证候评分低于对照组(P<0。05)。治疗后观察组I型前胶原氨基末端前肽(PINP)、I型胶原羧基端肽β特殊序列(β-CTX)低于对照组而骨形成蛋白6(BMP6)高于对照组(P<0。05)。治疗后观察组炎症因子白介素-1(IL-1)、核因子(NF-κB)、肿瘤坏死因子-α(TNF-α)低于对照组(P<0。05)。两组不良反应发生率比较差异无统计学意义(P>0。05)。结论:二仙汤辅治骨质疏松效果良好,且安全。
Objective:To observe the effect of Erxian Decoction on osteoporosis.Methods:Eighty-eight cases were randomly divided into the control group and the observation group,with 44 cases in each group.Both groups were treated with conventional western medicine,and the observation group were treated with Erxian Decoction in addition.Results:The total effective rate of the observation group was higher than that of the control group(P<0.05).The TCM syndrome score of the observation group was lower than that of the control group(P<0.05).After treatment,type I procollagen amino terminal propeptide(PINP)and type I collagen carboxy terminal peptide β special sequence(β-CTX)in the observation group were lower than those in the control group,while bone morphogenetic protein 6(BMP6)was higher than that in the control group(P<0.05).After treatment,the inflammatory factors interleukin-1(IL-1),nuclear factor(NF-κB)and tumor necrosis factor-α(TNF-α)in the observation group were lower than those in the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Erxian Decoction is effective and safe in the treatment of osteoporosis.

OsteoporosisErxian DecoctionControl treatment and observation

汪为、洪蕾、史云佳

展开 >

重庆医药高等专科学校附属第一医院,重庆 400060

重庆中医药学院,重庆 401331

骨质疏松 二仙汤 对照治疗观察

2024

实用中医药杂志
重庆医科大学中医药学院

实用中医药杂志

影响因子:0.546
ISSN:1004-2814
年,卷(期):2024.40(8)